Tarsus PharmaceuticalsÂ Inc (TARS) Financials

$77.89

$0.25 (0.32%)

As on 17-Sep-2026 12:37EDT

Market cap

$3,711 Mln

Revenue (TTM)

$606 Mln

P/E Ratio

--

P/B Ratio

10.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	606.33	451.36	182.95	17.45	25.82	57.03
Cost of Revenue	57.03	30.68	12.83	1.59	0.96	2.08
Gross Profit	549.30	420.68	170.13	15.85	24.86	54.95
Operating Expenses	597.84	491.65	290.70	159.01	87.57	67.11
Operating Profit (EBIT)	-48.54	-70.97	-120.57	-143.16	-62.71	-12.16
Other Income	--	--	--	--	-0.68	-1.65
Profit before Tax	-44.05	-64.36	-115.55	-135.89	-62.10	-13.77
Provision for Tax	2.42	2.06	--	0.71	0.00	0.06
Profit after Tax (Net Income)	-46.48	-66.42	-115.55	-135.89	-62.09	-13.83
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-62.09	-13.83

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	346.73	343.43	224.53	196.99	192.90	166.73
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	88.66	83.04	71.85	31.57	19.53	0.70
Current Liabilities	175.75	135.70	80.61	36.94	15.43	11.48
Total Liabilities	786.90	562.16	376.99	265.49	227.86	178.91

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	49.15	39.38	20.29	9.36	2.49	2.96
Current Assets	561.99	522.78	356.71	256.13	225.38	175.95
Total Assets	786.90	562.16	376.99	265.49	227.86	178.91
Total Debt*	88.66	93.64	72.45	30.22	20.21	1.89
Net Current Assets	386.24	387.09	276.09	219.20	209.95	164.47

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-12.45	-83.03	-117.49	-49.03	3.75
Cash Flow from Investing Activities	--	-42.12	-199.20	140.60	-144.63	-0.59
Cash from Financing Activities	--	143.39	154.66	130.18	93.99	0.02
Net Cash Inflow / Outflow	--	--	--	--	-99.67	3.18

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.08	-1.55	-3.00	-4.25	-2.42	-0.67
Cash EPS ($)	--	-1.51	-2.96	-4.23	-2.41	-0.66
Adjusted Book Value ($)	--	8.03	5.82	6.17	7.51	8.08
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.29	-2.15	-3.68	-1.91	0.18
Free Cash Flow per Share ($)	--	-0.52	-2.19	-3.85	-1.93	0.15

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-18.10	-44.09	-61.73	-32.53	-8.24
ROE (%)	-13.47	-23.39	-54.83	-69.71	-34.53	-8.31
ROA (%)	-6.77	-14.14	-35.97	-55.09	-30.53	-7.88
EBIT Margin (%)	-6.19	-12.28	-58.87	-759.71	-232.53	-24.15
Net Margin (%)	-7.67	-14.72	-63.16	-778.89	-247.05	-24.97
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	105.17	1.47	9.49	-0.32	-0.55	0.71
EBIT Growth (%)	54.63	48.54	18.74	-120.80	-335.89	48.63
Net Profit Growth (%)	49.48	42.52	14.97	-118.86	-349.06	48.43
EPS Growth (%)	53.58	0.48	0.30	-0.76	-2.61	0.47
Book Value Growth (%)	1.76	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-52.74	-18.48	-4.76	-6.06	-33.57
Price / Book Value	10.26	10.20	9.51	3.28	1.95	2.78
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.23	-59.31	-18.00	-3.41	-3.01	-21.86
Close Price ($)	62.94	81.88	55.37	20.25	14.66	22.50
High Price ($)	85.25	85.25	57.14	25.25	25.27	49.37
Low Price ($)	38.51	38.51	18.99	11.33	10.80	21.00
Market Cap ($ Cr)	3,711.05	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.21	0.27	0.32	0.15	0.10	0.01
Short term debt to equity ratio	--	--	0.00	0.00	0.00	0.01
Current Ratio	3.20	3.85	4.42	6.93	14.61	15.33
Quick Ratio	3.17	3.82	4.39	6.85	14.30	0.02
Interest Coverage	-4.11	-6.20	-14.46	-41.10	-29.08	-4.78

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	16.21	19.30	26.27	101.53	13.88	0.16
Asset Turnover	0.88	0.96	0.57	0.07	0.13	0.33
Receivable days	--	54.69	65.66	222.91	25.99	0.36
Inventory Days	--	41.61	81.54	902.15	34,506.83	30,924.64
Payable days	--	262.63	648.02	2,667.72	1,597.54	448.25
Cash Conversion Cycle	--	-166.32	-500.82	-1,542.66	32,935.28	30,476.76

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.